US EditionTargeting Cell Cycle Protein Sensitizes Tumors to Radiotherapy
Summary by Inside Precision Medicine
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Targeting Cell Cycle Protein Sensitizes Tumors to Radiotherapy
A study published in Science Immunology has revealed a previously unknown role for a cell cycle protein in helping cancer cells resist the immune response. Experiments in mice show that inhibiting this protein can sensitize tumors to radiotherapy and immunotherapy, offering a promising target to make existing cancer treatments more effective. The protein in question is known as budding uninhibited by benzimidazoles 1 (BUB1), a kinase located in…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
